Ranibizumab Treatment for Neovascular AMDRanibizumab Treatment for Neovascular AMD

Are there risk factors for being a 'reduced responder' to ranibizumab treatment for AMD, and if so, what should clinicians be aware of? BMC Ophthalmology
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology Journal Article Source Type: news